360iResearch predicts the global biosimilars market to grow from USD 6,738.15 million in 2018 to USD 31,872.68 million by 2025, at a Compound Annual Growth Rate (CAGR) of 24.86%. The year 2018 has been considered as the base year, while the forecast period is up to 2025.

360iResearch predicts the global specialty pharmaceuticals market to grow from USD 138.45 billion in 2017 to USD 510.45 billion by 2024, at a Compound Annual Growth Rate (CAGR) of 20.49%. The year 2017 has been considered as the base year, while the forecast period is up to 2024.

360iResearch predicts the global antifungal drug market to grow from USD 14.22 billion in 2017 to USD 18.92 billion by 2024, at a Compound Annual Growth Rate (CAGR) of 4.17%. The year 2017 has been considered as the base year, while the forecast period is up to 2024.

360iResearch predicts the global hiv vaccines market to grow from USD xx.xx million in 2017 to USD xx.xx million by 2024, at a Compound Annual Growth Rate (CAGR) of xx.xx%. The year 2017 has been considered as the base year, while the forecast period is up to 2024.

360iResearch predicts the global pharma regulatory management systems market to grow from USD xx.xx million in 2017 to USD xx.xx million by 2024, at a Compound Annual Growth Rate (CAGR) of xx.xx%. The year 2017 has been considered as the base year, while the forecast period is up to 2024.

360iResearch predicts the global pharmacovigilance market to grow from USD xx.xx million in 2017 to USD xx.xx million by 2024, at a Compound Annual Growth Rate (CAGR) of xx.xx%. The year 2017 has been considered as the base year, while the forecast period is up to 2024.

360iResearch predicts the global vinca alkaloid compounds market to grow from USD xx.xx million in 2017 to USD xx.xx million by 2024, at a Compound Annual Growth Rate (CAGR) of xx.xx%. The year 2017 has been considered as the base year, while the forecast period is up to 2024.

360iResearch predicts the global over the counter drugs market to grow from USD 290.85 billion in 2017 to USD 485.36 billion by 2024, at a Compound Annual Growth Rate (CAGR) of 7.59%. The year 2017 has been considered as the base year, while the forecast period is up to 2024.

360iResearch predicts the global deblistering machine market to grow from USD 0.30 billion in 2017 to USD 0.89 billion by 2024, at a Compound Annual Growth Rate (CAGR) of 16.60%. The year 2017 has been considered as the base year, while the forecast period is up to 2024.

360iResearch predicts the global sheep placenta extract market to grow from USD 349.57 million in 2017 to USD 972.68 million by 2024, at a Compound Annual Growth Rate (CAGR) of 15.74%. The year 2017 has been considered as the base year, while the forecast period is up to 2024.

360iResearch predicts the global radiopharmaceuticals market to grow from USD 3,365.65 million in 2017 to USD 4,962.55 million by 2024, at a Compound Annual Growth Rate (CAGR) of 5.70%. The year 2017 has been considered as the base year, while the forecast period is up to 2024.

360iResearch predicts the china biosimilars market to grow from USD 0.53 billion in 2017 to USD 7.12 billion by 2024, at a Compound Annual Growth Rate (CAGR) of 44.83%. The year 2017 has been considered as the base year, while the forecast period is up to 2024.

360iResearch predicts the global single-use bioprocessing market to grow from USD 3,731.47 million in 2018 to USD 12,218.47 million by 2025, at a Compound Annual Growth Rate (CAGR) of 18.47%. The year 2018 has been considered as the base year, while the forecast period is up to 2025.

360iResearch predicts the global pneumococcal vaccine market to grow from USD 6,485.35 million in 2017 to USD 9,854.35 million by 2024, at a Compound Annual Growth Rate (CAGR) of 6.16%. The year 2017 has been considered as the base year, while the forecast period is up to 2024.

360iResearch predicts the global small-molecule apis market to grow from USD 120,654.35 million in 2017 to USD 178,852.47 million by 2024, at a Compound Annual Growth Rate (CAGR) of 5.78%. The year 2017 has been considered as the base year, while the forecast period is up to 2024.

360iResearch predicts the global bovine serum albumin market to grow from USD xx.xx million in 2017 to USD xx.xx million by 2024, at a Compound Annual Growth Rate (CAGR) of xx.xx%. The year 2017 has been considered as the base year, while the forecast period is up to 2024.

360iResearch predicts the global antidiabetic drug market to grow from USD 56.93 billion in 2017 to USD 81.82 billion by 2024, at a Compound Annual Growth Rate (CAGR) of 5.32%. The year 2017 has been considered as the base year, while the forecast period is up to 2024.

360iResearch predicts the united states antidiabetic drug market to grow from USD xx.xx million in 2017 to USD xx.xx million by 2024, at a Compound Annual Growth Rate (CAGR) of xx.xx%. The year 2017 has been considered as the base year, while the forecast period is up to 2024.

360iResearch predicts the united states antifungal drug market to grow from USD xx.xx million in 2017 to USD xx.xx million by 2024, at a Compound Annual Growth Rate (CAGR) of xx.xx%. The year 2017 has been considered as the base year, while the forecast period is up to 2024.

360iResearch predicts the united states biosimilars market to grow from USD 855.47 million in 2018 to USD 3,808.85 million by 2025, at a Compound Annual Growth Rate (CAGR) of 23.78%. The year 2018 has been considered as the base year, while the forecast period is up to 2025.